Basic Information
Basic information for SNHG14-210-12aa-7
Peptide Name SNHG14-210-12aa-7
Genome Position chr15:25075864-25075866,25076857-25076889[+]
Species Human
Peptide Sequence MVALAWKEGLCL
Peptide Length 12
Unique No (SNHG14-224-12aa-8,SNHG14-227-12aa-1,SNHG14-231-12aa-1,SNHG14-235-12aa-1,SNHG14-248-12aa-4,SNHG14-254-12aa-4,SNHG14-268-12aa-1,SNHG14-269-12aa-1,SNHG14-272-12aa-1,SNHG14-282-12aa-2,SNHG14-290-12aa,SNHG14-291-12aa-2,SNHG14-299-12aa-2,SNHG14-304-12aa-2,SNHG14-305-12aa-2,SNHG14-309-12aa-3,SNHG14-318-12aa-1,SNHG14-319-12aa-2,SNHG14-323-12aa-5,SNHG14-332-12aa-4,SNHG14-333-12aa-3,SNHG14-340-12aa-2)
Grand Average of Hydropathicity 1.2417
Relative Molecular Mass 1531.82
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000549804;SNHG14-210
Transcript Length 24124
Coding Ability 0.3996
DNA Sequence Corresponding to Peptide ATGGTGGCGTTGGCATGGAAGGAAGGACTGTGTCTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :